Product: Human medicines

• Repurposing human medicines for veterinary use: Key considerations under EU Regulation 2019/6

  25.06.2026

  

• Q&A: What makes a strong Module 3 quality dossier

  27.05.2026

  

• Entering the EU pharmaceutical market: Q&A on new marketing authorisations

  27.05.2026

  

• 30 years of trusted regulatory expertise in the Baltics and EU

  20.05.2026

  

• Embedded expert support for RA & PV teams: a flexible alternative to hiring and full outsourcing

  13.05.2026

  

• Global healthcare company & Medfiles: ensuring quality and continuity in post-approval RA and PV activities

  04.05.2026

  

• How to implement common Baltic packs for human medicines

  28.04.2026

  

• How to write a strong Module 3 for a marketing authorisation application

  21.04.2026

  

• Q&A: What to know about EU marketing authorisation variations – procedures, timelines and classification

  21.04.2026